132 related articles for article (PubMed ID: 12635901)
1. Statistical issues on objective, design, and analysis of noninferiority active-controlled clinical trial.
Tsong Y; Wang SJ; Hung HM; Cui L
J Biopharm Stat; 2003 Feb; 13(1):29-41. PubMed ID: 12635901
[TBL] [Abstract][Full Text] [Related]
2. Choice of delta noninferiority margin and dependency of the noninferiority trials.
Tsong Y; Zhang J; Levenson M
J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
[TBL] [Abstract][Full Text] [Related]
3. Noninferiority testing beyond simple two-sample comparison.
Tsong Y; Chen WJ
J Biopharm Stat; 2007; 17(2):289-308. PubMed ID: 17365225
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
Tsong Y; Zhang J
J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
[TBL] [Abstract][Full Text] [Related]
5. Issues with statistical risks for testing methods in noninferiority trial without a placebo ARM.
Hung HM; Wang SJ; O'Neill R
J Biopharm Stat; 2007; 17(2):201-13. PubMed ID: 17365218
[TBL] [Abstract][Full Text] [Related]
6. A covariate-adjustment regression model approach to noninferiority margin definition.
Nie L; Soon G
Stat Med; 2010 May; 29(10):1107-13. PubMed ID: 20209669
[TBL] [Abstract][Full Text] [Related]
7. Mixed noninferiority margin and statistical tests in active controlled trials.
Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
[TBL] [Abstract][Full Text] [Related]
8. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
D'Agostino RB; Massaro JM; Sullivan LM
Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555
[TBL] [Abstract][Full Text] [Related]
9. A note on the conservativeness of the confidence interval approach for the selection of non-inferiority margin in the two-arm active-control trial.
Sankoh AJ
Stat Med; 2008 Aug; 27(19):3732-42. PubMed ID: 18407575
[TBL] [Abstract][Full Text] [Related]
10. A bootstrap-based test for establishing noninferiority in clinical trials.
Chen M; Kianifard F; Dhar SK
J Biopharm Stat; 2006 May; 16(3):357-63. PubMed ID: 16724490
[TBL] [Abstract][Full Text] [Related]
11. TACT method for non-inferiority testing in active controlled trials.
Wang SJ; Hung HM
Stat Med; 2003 Jan; 22(2):227-38. PubMed ID: 12520559
[TBL] [Abstract][Full Text] [Related]
12. Some fundamental issues with non-inferiority testing in active controlled trials.
James Hung HM; Wang SJ; Tsong Y; Lawrence J; O'Neil RT
Stat Med; 2003 Jan; 22(2):213-25. PubMed ID: 12520558
[TBL] [Abstract][Full Text] [Related]
13. Alternatives for discounting in the analysis of noninferiority trials.
Snapinn SM
J Biopharm Stat; 2004 May; 14(2):263-73. PubMed ID: 15206525
[TBL] [Abstract][Full Text] [Related]
14. Hypotheses and type I error in active-control noninferiority trials.
Chen G; Wang YC; Chi GY
J Biopharm Stat; 2004 May; 14(2):301-13. PubMed ID: 15206528
[TBL] [Abstract][Full Text] [Related]
15. Randomization as a basis for inference in noninferiority trials.
Wiens BL
Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
[TBL] [Abstract][Full Text] [Related]
16. Choice of lambda-margin and dependency of non-inferiority trials.
Tsong Y; Levenson M; Zhang J; Zhong J
Stat Med; 2008 Feb; 27(4):520-8. PubMed ID: 17617797
[TBL] [Abstract][Full Text] [Related]
17. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
Woods SW; Gueorguieva RV; Baker CB; Makuch RW
Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
[TBL] [Abstract][Full Text] [Related]
18. On non-inferiority analysis based on delta-method confidence intervals.
Rothmann MD; Tsou HH
J Biopharm Stat; 2003 Aug; 13(3):565-83. PubMed ID: 12921402
[TBL] [Abstract][Full Text] [Related]
19. Placebo or active control trials of antipsychotic drugs?
Fleischhacker WW; Czobor P; Hummer M; Kemmler G; Kohnen R; Volavka J
Arch Gen Psychiatry; 2003 May; 60(5):458-64. PubMed ID: 12742866
[TBL] [Abstract][Full Text] [Related]
20. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
Carroll KJ
Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]